PET Scan Test for Slow-Growing Lymphoma
Part of Blood & lymphatic, Cancer clinical trials.
This trial uses a special PET scan to take detailed pictures of slow-growing lymphomas, likely before or after your regular treatment scan. It may help your doctor see exactly where the lymphoma is in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a slow-growing type of lymphoma (like marginal zone, Waldenstrom's, CLL/SLL, or mantle cell lymphoma).
- You will have or already have a PET scan scheduled in the next 3 to 6 months.
- You can lie flat and still for at least 30 minutes.
- You feel well enough for daily activities (ECOG score 0, 1, or 2).
- You do not have severe kidney problems or allergies to radioactive tracers, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a lower dose of radiation than usual works well for people with slow-growing B-cell lymphomas. It aims to reduce side effects while still controlling the disease.
This trial looks at whether PET/CT scans can better predict outcomes in people with fast-growing lymphoma. If you are newly diagnosed and receiving standard treatment, the study may help refine how response is evaluated.
This study uses a special PET/CT scan to look at the environment around your lymphoma. The goal is to see if this scan can predict how well your treatment will work and your long-term outcome.
This study uses a special type of scan (F-18 FDG PET/CT) to better understand metabolism in adults with lymphoma. The results may help doctors plan treatment more effectively.
This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.
This trial tests a special PET scan (68Ga-grazytracer) to see if it can predict early whether immunotherapy is working in people with lung cancer that can be surgically removed. If successful, this scan could help doctors tailor treatment sooner.
Hear when a new Indolent B-Cell Non-Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.